Moxifloxacin Ratiopharm

Moxifloxacin, the active ingredient in Moxifloxacin Ratiopharm, is a fluoroquinolone antibiotic presented as an oral dosage form for systemic use. It treats a range of bacterial infections, particularly respiratory and skin infections, in adult patients as prescribed by a healthcare professional.

GNH USA supplies Moxifloxacin Ratiopharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Moxifloxacin is a broad‑spectrum fluoroquinolone used to treat bacterial infections affecting the respiratory tract and skin.

- Community‑acquired pneumonia: eradicates the causative bacteria and improves clinical outcomes. - Acute bacterial sinusitis: reduces sinus inflammation and clears infection. - Acute bacterial exacerbation of chronic bronchitis: shortens symptom duration and prevents complications. - Skin and skin‑structure infections: eliminates pathogenic bacteria and promotes wound healing.

Moxifloxacin may cause adverse reactions that vary in frequency and severity.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Diarrhea: loose stools, often self‑limiting. - Headache: transient cranial discomfort. - Dizziness: sensation of light‑headedness.

Serious or Rare Side Effects: - Tendon rupture: sudden tendon pain or swelling, especially in the Achilles. - QT interval prolongation: risk of cardiac arrhythmia. - Severe allergic reaction: rash, swelling, or anaphylaxis requiring immediate medical attention.

Before prescribing Moxifloxacin, clinicians should consider several safety aspects.

- Renal function assessment: adjust use in patients with impaired kidney function. - Tendon health monitoring: advise patients to report tendon pain or inflammation. - QT‑prolonging drug avoidance: avoid concurrent use with other QT‑prolonging agents. - Seizure history evaluation: use cautiously in patients with a history of seizures. - Hepatic impairment consideration: monitor liver function tests during therapy. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Moxifloxacin can interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - QT‑prolonging agents: co‑administration may increase risk of cardiac arrhythmias. - Antacids containing aluminum or magnesium: reduce absorption of moxifloxacin. - Warfarin: may enhance anticoagulant effect and raise INR.

Moderate Interactions (Monitor Closely): - Corticosteroids: combined use may raise the risk of tendon rupture. - Theophylline: moxifloxacin can increase theophylline plasma concentrations, requiring monitoring.